BioRem Days Of Payables Outstanding from 2010 to 2024

BRM Stock  CAD 3.00  0.02  0.67%   
BioRem Days Of Payables Outstanding yearly trend continues to be fairly stable with very little volatility. Days Of Payables Outstanding will likely drop to 105.31 in 2024. During the period from 2010 to 2024, BioRem Days Of Payables Outstanding regression line of quarterly data had mean square error of  1,323 and geometric mean of  84.69. View All Fundamentals
 
Days Of Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
123.44334089
Current Value
105.31
Quarterly Volatility
36.17973806
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 281.4 K, Total Revenue of 18.5 M or Gross Profit of 5.5 M, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 2.89. BioRem financial statements analysis is a perfect complement when working with BioRem Valuation or Volatility modules.
  
This module can also supplement various BioRem Technical models . Check out the analysis of BioRem Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.